AGISOL LLC - CDER STREAMLINE PROCESS AND ENHANCE FUNCTIONS FOR NEW DRUG REVIEW

PIID: 75F40123F80143

Effective Date: Jun 8, 2023End Date: Closes in 101 days

Key Details

Dollars Obligated

$2.3M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Food and Drug Administration

Contract Vehicle

GSA MAS

Parent IDIQ (PIID)

47QTCA18D0071

Description

CDER STREAMLINE PROCESS AND ENHANCE FUNCTIONS FOR NEW DRUG REVIEW

Context & Analysis

Department of Health and Human Services obligated $2,338,069.25 to AGISOL LLC for cder streamline process and enhance functions for new drug review. The contract is scheduled through Jul 31, 2026 — approximately 3 months remaining. This award is one of several similar procurements from Department of Health and Human Services — related awards are listed below.